GENMAB AS SP.ADR/1/10DK 1 (GE91) — Net Asset Quality Index
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Net Asset Quality Index of 45.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €12.87 Billion minus total liabilities of €7.03 Billion yields net assets of €5.85 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read GE91 current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
GENMAB AS SP.ADR/1/10DK 1 Net Asset Quality Index Over Time (2021–2025)
This chart shows how GENMAB AS SP.ADR/1/10DK 1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 45.4%, representing net assets of €5.85 Billion against total assets of €12.87 Billion EUR. For live market cap and overall valuation, see GE91 market cap.
Annual Net Asset Quality Index for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check GENMAB AS SP.ADR/1/10DK 1 strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.4% | €5.85 Billion | €12.87 Billion | €7.03 Billion | ▼ -34.7 pp |
| 2024 | 80.1% | €5.12 Billion | €6.39 Billion | €1.27 Billion | ▼ -9.5 pp |
| 2023 | 89.6% | €4.69 Billion | €5.24 Billion | €546.23 Million | ▼ -1.0 pp |
| 2022 | 90.6% | €3.93 Billion | €4.33 Billion | €408.32 Million | ▲ +0.5 pp |
| 2021 | 90.1% | €3.38 Billion | €3.75 Billion | €370.09 Million | — |